Pamela Emengo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pamela Emengo has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- James C. Y. Dunn
Division of Pediatric Surgery, Department of Surgery Stanford University School of Medicine Stanford California USA
3 shared publications Daniel Nicastri
The Mount Sinai Hospital, New York, NY, USA
2 shared publicationsHelene Nepomuceno
Division of Pediatric Surgery, Department of Surgery Stanford University School of Medicine Stanford California USA
2 shared publicationsJohn Jacob
Division of Thoracic and Esophageal Surgery, Thomas Jefferson University Hospitals, Philadelphia, PA, USA
2 shared publicationsAdil A. Shah
Department of Pediatric Surgery, Children's Nebraska, Omaha NE, USA
1 shared publicationAnne-Laure Thomas
Division of Pediatric Surgery, Department of Surgery, Stanford University, Stanford, CA
1 shared publication
Latest Publications
- 7 October 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (10)
Lengthening Bowel Endoscopically: Hydrogel‐Enabled Endoscopic Spring‐Mediated Distraction Enterogenesis
We evaluated the feasibility to lengthen small bowel endoscopically utilizing a spring device constrained by an engineered, slow biodegrading, hyaluronan and elastin‐like protein (HELP) hydrogel as a potential treatment for short bowel syndrome. While we previously demonstrated that the HELP hydrogel could provide device confinement and enable non‐invasive device removal, here we demonstrate that the HELP hydrogel can also be designed to be catheter‐injectable while still being stiff enough to achieve device confinement. Six pigs underwent endoscopic spring‐mediated distraction enterogenesis (ESMDE), the lengthening of existing intestine using axial mechanical force. A compressed spring that was encapsulated in gelatin was placed into pig jejunum via enterotomy. The spring was confined on each end by endoscopic catheter‐injection of HELP gel into the intestinal submucosa to cause transient luminal narrowing. The gelatin capsule rapidly biodegrades to deploy the spring, while the HELP gel slowly biodegrades to transiently constrain the device, applying tension to the bowel segment. On postoperative day 7, of the six pigs that underwent ESMDE, four had successful bowel lengthening, up to 172% of the initial length. None of the animals experienced any complications such as obstruction or perforation, and there were no mortalities. In this proof‐of‐concept study, we demonstrate that a hydrogel can be designed with the appropriate catheter‐injection properties, stiffness, and biodegradation rate to achieve hydrogel‐enabled, endoscopic spring‐mediated distraction enterogenesis, making it a possible future treatment for short bowel syndrome.
- 7 October 2026
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 114 (10)
Lengthening Bowel Endoscopically: Hydrogel‐Enabled Endoscopic Spring‐Mediated Distraction Enterogenesis
We evaluated the feasibility to lengthen small bowel endoscopically utilizing a spring device constrained by an engineered, slow biodegrading, hyaluronan and elastin‐like protein (HELP) hydrogel as a potential treatment for short bowel syndrome. While we previously demonstrated that the HELP hydrogel could provide device confinement and enable non‐invasive device removal, here we demonstrate that the HELP hydrogel can also be designed to be catheter‐injectable while still being stiff enough to achieve device confinement. Six pigs underwent endoscopic spring‐mediated distraction enterogenesis (ESMDE), the lengthening of existing intestine using axial mechanical force. A compressed spring that was encapsulated in gelatin was placed into pig jejunum via enterotomy. The spring was confined on each end by endoscopic catheter‐injection of HELP gel into the intestinal submucosa to cause transient luminal narrowing. The gelatin capsule rapidly biodegrades to deploy the spring, while the HELP gel slowly biodegrades to transiently constrain the device, applying tension to the bowel segment. On postoperative day 7, of the six pigs that underwent ESMDE, four had successful bowel lengthening, up to 172% of the initial length. None of the animals experienced any complications such as obstruction or perforation, and there were no mortalities. In this proof‐of‐concept study, we demonstrate that a hydrogel can be designed with the appropriate catheter‐injection properties, stiffness, and biodegradation rate to achieve hydrogel‐enabled, endoscopic spring‐mediated distraction enterogenesis, making it a possible future treatment for short bowel syndrome.
- 20 August 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (11) , 162594
Antibiotic Stewardship in Pediatric Complicated Appendicitis: Assessing the Role of Oral Antibiotics After Discharge
- 20 August 2025
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 60 (11) , 162594
Antibiotic Stewardship in Pediatric Complicated Appendicitis: Assessing the Role of Oral Antibiotics After Discharge
- Open Access
- 13 June 2025
- Published by Elsevier in Intestinal Failure
- Vol. 5, 100064
Colonic dilation is associated with increased central line associated blood stream infection for patients with intestinal failure
- 13 June 2025
- Published by Elsevier in Intestinal Failure
- Vol. 5, 100064
Open AccessColonic dilation is associated with increased central line associated blood stream infection for patients with intestinal failure
- 1 July 2024
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 19 (4) , 443-445
Capsular Fibrosis as a Suggested Cause of Failure of Magnetic Sphincter Augmentation
- 1 July 2024
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 19 (4) , 443-445
Capsular Fibrosis as a Suggested Cause of Failure of Magnetic Sphincter Augmentation
- 1 May 2024
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 19 (3) , 306-309
Robotic Magnetic Sphincter Augmentation Device Removal
Although most patients with reflux can be managed with medical therapy, some require surgical intervention to manage their disease. Newer technologies, such as magnetic sphincter augmentation (MSA), have been promoted as the replacement of fundoplication. However, as time has elapsed, our institution noticed the need for the removal of MSA devices. Although a few reports have described MSA device removals, we provide a deeper explanation of how to perform a robotic device removal. Our article describes the technical steps and includes a video to demonstrate how to complete the surgery robotically.
- 1 May 2024
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 19 (3) , 306-309
Robotic Magnetic Sphincter Augmentation Device Removal
Although most patients with reflux can be managed with medical therapy, some require surgical intervention to manage their disease. Newer technologies, such as magnetic sphincter augmentation (MSA), have been promoted as the replacement of fundoplication. However, as time has elapsed, our institution noticed the need for the removal of MSA devices. Although a few reports have described MSA device removals, we provide a deeper explanation of how to perform a robotic device removal. Our article describes the technical steps and includes a video to demonstrate how to complete the surgery robotically.